| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/05/2013 | WO2013180747A2 Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life |
| 12/05/2013 | WO2013180698A1 Use of faah antagonists for treating dry eye and ocular pain |
| 12/05/2013 | WO2013180676A1 A new sustained release formulation |
| 12/05/2013 | WO2013180675A1 Tablet formulation comprising dapoxetine |
| 12/05/2013 | WO2013180606A1 Composition for treatment of warts |
| 12/05/2013 | WO2013180501A1 Recombinant adenovirus for simultaneously expressing pig interferon alpha and pig interferon gamma |
| 12/05/2013 | WO2013180462A1 A composition comprising the extract of pine tree leaf or the compounds isolated therefrom for the prevention and treatment of cancer disease by inhibiting hpv virus and the uses thereby |
| 12/05/2013 | WO2013180458A1 Crosslinked hydrogel for drug delivery, and method for preparing the hydrogel |
| 12/05/2013 | WO2013180403A1 Process for preparing gefitinib and an intermediate used for preparing thereof |
| 12/05/2013 | WO2013180310A1 Drug for preventing and/or treating polycystic kidney disease |
| 12/05/2013 | WO2013180274A1 Chemotherapy selection method for stomach cancer patients |
| 12/05/2013 | WO2013180271A1 Prodrug of fluorine-containing amino acid |
| 12/05/2013 | WO2013180265A1 Heterocyclic compound |
| 12/05/2013 | WO2013180240A1 Medicine comprising combination of general anesthetic drug and hydrogen |
| 12/05/2013 | WO2013180229A1 Composition for hair growth |
| 12/05/2013 | WO2013180197A1 NOVEL β-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME |
| 12/05/2013 | WO2013180194A1 Fused heterocyclic compound |
| 12/05/2013 | WO2013180193A1 Fused heterocyclic compound |
| 12/05/2013 | WO2013180183A1 Aromatic heterocyclic derivative and pharmaceutical |
| 12/05/2013 | WO2013180149A1 Deuterated nitrogenated heterocyclic carboxamide derivative or salt thereof |
| 12/05/2013 | WO2013180140A1 Dihydroorotic acid dehydrogenase inhibitor |
| 12/05/2013 | WO2013180128A1 4-[4-(5-membered aromatic heterocyclic carbonyl ureide)phenyloxy]quinoline derivative |
| 12/05/2013 | WO2013180066A1 Pyridine derivative having inhibitory effect on tlr |
| 12/05/2013 | WO2013179910A1 Agent for preventing and/or treating peripheral neuropathic pain caused by anti-cancer drug |
| 12/05/2013 | WO2013179309A1 Novel compounds as memory enhancers |
| 12/05/2013 | WO2013179305A1 Ibandronate sodium solid dispersion |
| 12/05/2013 | WO2013179292A1 Therapeutic oligonucleotides comprising pyrazolotriazine nucleotide analogues |
| 12/05/2013 | WO2013179289A1 Pyrazolotriazolyl nucleoside analogues and oligonucleotides comprising them |
| 12/05/2013 | WO2013179253A1 Dose combination comprising nsaid and steroidal anti-inflammatory agent for treating post operative ocular inflammation |
| 12/05/2013 | WO2013179248A1 Pharmaceutical compositions of pemetrexed |
| 12/05/2013 | WO2013179153A1 Compositions and methods for treatment of neurological degenerative disorders and neurological diseases |
| 12/05/2013 | WO2013179144A2 Chemical suppressors of neurotoxicity in synucleinopathic diseases |
| 12/05/2013 | WO2013179067A1 An icam-1 anti sense for the treatment of inflammation and pain in a rectal stump |
| 12/05/2013 | WO2013179057A1 Method of synthesising sulforaphane |
| 12/05/2013 | WO2013179056A1 Sulforaphane isolation and purification |
| 12/05/2013 | WO2013179049A1 Spiro derivatives as voltage - gated sodium channel modulators |
| 12/05/2013 | WO2013179034A1 New compounds |
| 12/05/2013 | WO2013179033A1 Pteridines as fgfr inhibitors |
| 12/05/2013 | WO2013179024A1 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases |
| 12/05/2013 | WO2013178880A1 Composition for preventing headaches |
| 12/05/2013 | WO2013178856A1 Composition for use as an antifungal agent |
| 12/05/2013 | WO2013178846A1 Pharmaceutical composition comprising diacetylmorphine and naloxone for oral administration |
| 12/05/2013 | WO2013178821A1 Inhibitors of the notch signalling pathway and secretion for use in medicine |
| 12/05/2013 | WO2013178816A1 Heterocycles capable of modulating t-cell responses, and methods of using same |
| 12/05/2013 | WO2013178815A1 Bicyclic heterocycles capable of modulating t-cell responses, and methods of using same |
| 12/05/2013 | WO2013178811A1 Paliperidone implant formulation |
| 12/05/2013 | WO2013178810A1 Ornithine- and lysine-derivatives for the treatment of pain |
| 12/05/2013 | WO2013178782A1 Allosteric inhibitors of ns3 protease from hepatitis c virus |
| 12/05/2013 | WO2013178763A1 Methods for treating vestibulotoxicity |
| 12/05/2013 | WO2013178760A1 Oil/water-emulsion-type topical compositions containing a retinoid |
| 12/05/2013 | WO2013178759A1 Topical compositions in the form of a gel containing a particular solubilised retinoid |
| 12/05/2013 | WO2013178758A1 O/w-emulsion-type topical pharmaceutical compositions containing a retinoid |
| 12/05/2013 | WO2013178756A1 Dermatological composition including oleosomes and retinoids, method for preparing same and use thereof |
| 12/05/2013 | WO2013178749A1 Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing same, method of producing same and use thereof in dermatology |
| 12/05/2013 | WO2013178745A1 Aqueous-gel-type topical compositions in the form of a homogenous suspension of an active principle of the class of retinoids containing at least one hydrophobic silica |
| 12/05/2013 | WO2013178744A1 Emulsion-type, emulsifier-free topical compositions containing stabilising particles |
| 12/05/2013 | WO2013178743A1 Microcapsules containing retinoids, method for preparing same, and pharmaceutical compositions containing same |
| 12/05/2013 | WO2013178742A1 Novel dosage form and formulation of abediterol |
| 12/05/2013 | WO2013178715A1 Induction of arteriogenesis with an no (nitric oxide) donor |
| 12/05/2013 | WO2013178713A1 Stabilized granules containing glyceryl trinitrate for inducing arteriogenesis |
| 12/05/2013 | WO2013178622A1 New monosaccharide derivatives and biological applications thereof |
| 12/05/2013 | WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives |
| 12/05/2013 | WO2013178587A1 Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media |
| 12/05/2013 | WO2013178581A1 Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients |
| 12/05/2013 | WO2013178575A1 New indanyloxyphenylcyclopropanecarb oxylic acids |
| 12/05/2013 | WO2013178572A1 Triazolo compounds as pde10 inhibitors |
| 12/05/2013 | WO2013178570A1 Substituted pyrrolidine-2-carboxamides |
| 12/05/2013 | WO2013178569A1 Pyrrolidino heterocycles |
| 12/05/2013 | WO2013178565A1 Genotype- or phenotype-based drug formulation |
| 12/05/2013 | WO2013178545A1 Acid ceramidase inhibitors and their use as medicaments |
| 12/05/2013 | WO2013178362A1 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma] |
| 12/05/2013 | WO2013178322A1 Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases |
| 12/05/2013 | WO2013178320A1 Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide |
| 12/05/2013 | WO2013178214A1 Pharmaceutical pemetrexed solution |
| 12/05/2013 | WO2013178075A1 N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and antitumor application thereof |
| 12/05/2013 | WO2013178065A1 Amino acid copper complex with effects of preventing alopecia, growing hair and protecting skin, preparation method and application |
| 12/05/2013 | WO2013178064A1 Glucopyranosyl derivative, preparation method thereof, and pharmaceutical application thereof |
| 12/05/2013 | WO2013178031A1 New forms of telaprevir and preparation methods thereof |
| 12/05/2013 | WO2013178021A1 Pyrrole [2, 1-f][1, 2, 4] triazine derivative and antitumor effect thereof |
| 12/05/2013 | WO2013177983A1 Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof |
| 12/05/2013 | WO2013177978A1 Pegylated artesunate derivative, pharmaceutical composition and use thereof |
| 12/05/2013 | WO2013177963A1 Injection-use pantoprazole sodium lyophilized powder composition and preparation method therefor |
| 12/05/2013 | WO2013177927A1 Injection-use esomeprazole sodium lyophilized powder composition and preparation method therefor |
| 12/05/2013 | WO2013177907A1 Injection-use levorotatory-pantoprazole sodium lyophilized powder composition and preparation method therefor |
| 12/05/2013 | WO2013177880A1 Compound ambroxol hydrochloride composition and preparation method therefor |
| 12/05/2013 | WO2013177699A1 Inflammation-enabling polypeptides and uses thereof |
| 12/05/2013 | WO2013177672A1 Pharmaceutical composition of entecavir and process of manufacturing |
| 12/05/2013 | WO2013177633A1 Combination therapy involving a vascular disrupting agent and an agent which targets hypoxia |
| 12/05/2013 | WO2013177608A1 Method of treating scedosporium spp. infection |
| 12/05/2013 | WO2013169746A3 N-ethyl-4-hydroxyl-1-methyl-5- (methyl(2,3,4,5,6-pentahydroxyhexyl) amino) -2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide |
| 12/05/2013 | WO2013155528A3 Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels |
| 12/05/2013 | WO2013153479A3 Indole and indazole compounds that activate ampk |
| 12/05/2013 | WO2013153450A3 Coriolus versicolor extracts, methods of isolating biologically-active compounds, and uses thereof |
| 12/05/2013 | WO2013153161A3 Polymorph of rilpivirine hydrochloride |
| 12/05/2013 | WO2013153155A3 The use of mirna particles and mirna antagomir for diagnostics, prevention and treatment of multiple sclerosis |
| 12/05/2013 | WO2013152351A3 Fusion polypeptides and methods of use thereof |
| 12/05/2013 | WO2013150406A3 Siphonochilone and related compounds and uses thereof |
| 12/05/2013 | WO2013147651A3 Pharmaceutical composition having antimicrobial and bacteriostatic action(alternatives) |
| 12/05/2013 | WO2013147649A3 Inhibitors of the pi3k/akt/ikk/nf-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for the prophylaxis and treatment of viral diseases |
| 12/05/2013 | WO2013144976A3 Chewable soft gelatin capsule dosage form of mucolytic agents |